There are 15,361 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
7 December 2022
BB20221207
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
22 June 2022
BB20220623
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
17 June 2022
BB20220620
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Questions and Answers
Date answered:
16 August 2021
S6W-01182
There is further detailed advice available, which is continuously updated in line with protection levels advice, for those who have been shielding for health reasons published here: Coronavirus (COVID-19): shielding advice and support - gov.scot (www.gov.scot) . Like all medicines, no vaccine is completely effective, but we do know the vaccination of a h...
Official Report
Meeting date:
15 January 2013
Meeting of the Parliament 15 January 2013
Orphan and Ultra-orphan Medicines (Value-based Pricing) 1. To ask the Scottish Government how value-based pricing will impact on the availability of orphan and ultra-orphan medicines such as Kalydeco.
Questions and Answers
Date answered:
7 January 2019
S5W-20517
To ask the Scottish Government what its response is to the call by Breast Cancer Now for Perjeta to be made routinely available for people with secondary breast cancer. On 10 December the Scottish Medicines Consortium announced that they had recommended Perjeta for use in NHS Scotland for the neoadjuvant treatment of breast cancer.
Questions and Answers
Date answered:
6 June 2018
S5W-16883
The Scottish Government hopes that Vertex Pharmaceutical will re-submit an application for Orkambi to the Scottish Medicines Consortium, at a fair price. Scottish Government officials will meet with representatives of the company this month.
Questions and Answers
Date answered:
24 November 2016
S5W-04698
To ask the Scottish Government, in light of the Scottish Medicines Consortium's decision not to recommend nivolumab for use by patients with advanced renal cell carcinoma, what options it is considering to make this treatment available.
Official Report
Meeting date:
14 May 2013
Health and Sport Committee 14 May 2013
In the English context, we have said that individual patients who are benefiting from medicines through the cancer drugs fund will continue to receive those medicines.
Official Report
Meeting date:
9 May 2017
Health and Sport Committee 09 May 2017
We are extremely tight for time this morning, so I ask for short and sharp questions and answers. 10:45 I am interested in the tension between data-driven, evidence-based medicine and the “intuitively sensible” approach, which I think is an issue throughout medicine but particularly in public health.
